help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2009.080983 on July 9, 2009

Published online before print July 9, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2009.080983v1
175/2/580    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, G.
Right arrow Articles by Harris, D. C.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, G.
Right arrow Articles by Harris, D. C.H.
(American Journal of Pathology. 2009;175:580-591.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080983

Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-β1 in Renal Tubular Epithelial Cells

Guoping Zheng*, James Guy Lyons{dagger}, Thian Kui Tan*, Yiping Wang*, Tzu-Ting Hsu*, Danqing Min{ddagger}, Lena Succar*, Gopala K. Rangan*, Min Hu§, Beric R. Henderson, Stephen I. Alexander§ and David C.H. Harris*

From the Center for Transplantation and Renal Research,* and the Gene Expression Laboratory, the University of Sydney at Westmead Millennium Institute, Sydney; the Sydney Head & Neck Cancer Institute,{dagger} Sydney Cancer Center, Royal Prince Alfred Hospital and Dermatology Research Laboratories, and the Department of Endocrinology,{ddagger} University of Sydney, Sydney; the Center for Kidney Research,§ The Children’s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia

Epithelial-mesenchymal transition (EMT) plays an important role in organ fibrosis, including that of the kidney. Loss of E-cadherin expression is a hallmark of EMT; however, whether the loss of E-cadherin is a consequence or a cause of EMT remains unknown, especially in the renal system. In this study, we show that transforming growth factor (TGF)-β1-induced EMT in renal tubular epithelial cells is dependent on proteolysis. Matrix metalloproteinase-mediated E-cadherin disruption led directly to tubular epithelial cell EMT via Slug. TGF-β1 induced the proteolytic shedding of E-cadherin, which caused the nuclear translocation of β-catenin, the transcriptional induction of Slug, and the repression of E-cadherin transcription in tubular epithelial cells. These findings reveal a direct role for E-cadherin and for matrix metalloproteinases in causing EMT downstream of TGF-β1 in fibrotic disease. Specific inhibition rather than activation of matrix metalloproteinases may offer a novel approach for treatment of fibrotic disease.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y. Liu
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
J. Am. Soc. Nephrol., February 1, 2010; 21(2): 212 - 222.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.